Mumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food ...

Lupin receives tentative USFDA approval for its generic HIV treatment, combining Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide. The drug, equivalent to Janssen's Symtuza, has ...

The company has received tentative approval from the US Food and Drug Administration (USFDA) for Darunavir, Cobicistat, ...

Lupin Ltd has received tentative approval from the FDA for its generic version of a combination HIV treatment.

Lupin gained 3.66% to Rs 2,188 after the company announced that it has received a tentative approval from the U.S. Food and Drug Administration (USFDA) for its ANDA for Darunavir, Cobicistat, ...

Existing treatment criteria for chronic hepatitis B virus (HBV) infection are mainly based on data from observational studies, such as the REVEAL study from Taiwan, which was initiated in the early ...

Lupin receives US FDA tentative approval for generic Symtuza tablets: Our Bureau, Mumbai Monday, February 3, 2025, 13:45 Hrs [IST] Global pharma major Lupin Limited (Lupin) announ ...

The drugs include Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide tablets and the company is the exclusive first-to-file for this products ...

In this month’s issue, the Sexpert advises readers on how to navigate discussions of PrEP and sexual health while in the ...

Collaboration with South Korean university advocates early antiviral treatment for hepatitis B | Feb. 5, 2025 13:09 ...

Lupin has obtained approval from the USFDA to market a generic form of an HIV medication. The approved drug, equivalent to Symtuza tablets, positions Lupin as the exclusive first-to-file. The tablets ...